CompletedPhase 2NCT00611351
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Nebraska
- Principal Investigator
- Marcel Devetten, MDUniversity of Nebraska
- Intervention
- anti-thymocyte globulin(biological)
- Enrollment
- 5 enrolled
- Eligibility
- 19-65 years · All sexes
- Timeline
- 2005 – 2008
Study locations (1)
- Unversity of Nebraska Medical Center, Omaha, Nebraska, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00611351 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.